Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M. Shingarova"'
Autor:
O. Lomakina, M. Shingarova, A. Fetisova, M. Gautier, I. Zybkova, I. Kriulin, Rina Denisova, Ekaterina Alexeeva, K. Chibisova, K. Isaeva, I. Tsulukiya, N. Tkachenko, A. Chomakhidze, A. Mamutova, D. Vankova, E. Krekhova, T. Dvoryakovskaya
Publikováno v:
Annals of the Rheumatic Diseases. 80:100.2-100
Background:The safety of vaccination of children with rheumatic diseases is determined not only by the risk of adverse events but also by the risk of exacerbation of the disease. The simultaneous administration of several vaccines can increase the li
Autor:
Alina Alshevskaya, K. Isaeva, I. Kriulin, A. Fetisova, O. Lomakina, M. Shingarova, Andrey Moskalev, M. Gautier, A. Chomakhidze, E. Chistyakova, Ekaterina Alexeeva, A. Mamutova, D. Vankova, Rina Denisova, E. Krekhova, T. Dvoryakovskaya
Publikováno v:
Annals of the Rheumatic Diseases. 79:1780.1-1781
Background:Results from various phase 3 clinical studies have demonstrated the efficacy of canakinumab to treat patients with systemic juvenile idiopathic arthirtis (sJIA). However, limited information is available on the long-term efficacy and safet
Autor:
M. Shingarova, O. Lomakina, A. Fetisova, Andrey Moskalev, E. Krekhova, T. Dvoryakovskaya, A. Chomakhidze, D. Vankova, I. Kriulin, Rina Denisova, Alina Alshevskaya, E. Chistyakova, K. Isaeva, A. Mamutova, Ekaterina Alexeeva, M. Gautier
Publikováno v:
Annals of the Rheumatic Diseases. 79:1202.2-1203
Background:Early-onset form of systemic juvenile idiopathic arthritis (sJIA) often presents severe disease course. Choosing the optimal therapy option as first-line treatment is necessary for rapid improvement of patients’ quality of live and preve
Autor:
Rina Denisova, A. Chomakhidze, Andrey Moskalev, D. Vankova, M. Gautier, Alina Alshevskaya, E. Krekhova, Ekaterina Alexeeva, T. Dvoryakovskaya, A. Mamutova, M. Shingarova, E. Chistyakova, O. Lomakina, I. Kriulin, K. Isaeva, A. Fetisova
Publikováno v:
Annals of the Rheumatic Diseases. 79:489.3-489
Background:Anti-IL-17A biologic drug secukinumab (SEC) proved to be effective for treatment of psoriatic arthritis. However data about its efficacy in juvenile idiopathic arthritis (JIA) are restricted to off-label experience.Objectives:To evaluate t
Autor:
K. Savostyanov, I. Kriulin, A. Mamutova, A. Pushkov, O. Lomakina, M. Gautier, M. Shingarova, A. Fetisova, Alina Alshevskaya, E. Chistyakova, Ekaterina Alexeeva, E. Krekhova, T. Dvoryakovskaya, A. Chomakhidze, K. Isaeva, R. Tepaev, N. Zhurkova, Andrey Moskalev, Rina Denisova, D. Vankova
Publikováno v:
Annals of the Rheumatic Diseases. 79:829.2-830
Background:Cryopyrine-associated periodic syndromes (CAPS) are a group of rare congenital auto-inflammatory diseases (AID) that include diseases such as familial cold auto-inflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), and CINCA/NOMID syn
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.